Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors

NCT06658951 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2-positive Advanced Malignant Solid Tumors

Interventions

BIOLOGICAL: Anti-HER2 CAR-T cells

Sponsor

UTC Therapeutics Inc.

Collaborators

[object Object]